{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:08:33Z","timestamp":1791925713978,"version":"4.3.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T00:00:00Z","timestamp":1487203200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T00:00:00Z","timestamp":1487203200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alzheimer\u2019s disease (AD) is characterized by extensive neuron loss that accompanies profound impairments in memory and cognition. We examined the neuronally directed effects of the retinoid X receptor agonist bexarotene in an aggressive model of AD. We report that a two week treatment of 3.5 month old 5XFAD mice with bexarotene resulted in the clearance of intraneuronal amyloid deposits. Importantly, neuronal loss was attenuated by 44% in the subiculum in mice 4 months of age and 18% in layer V of the cortex in mice 8 months of age. Moreover, bexarotene treatment improved remote memory stabilization in fear conditioned mice and improved olfactory cross habituation. These improvements in neuron viability and function were correlated with significant increases in the levels of post-synaptic marker PSD95 and the pre-synaptic marker synaptophysin. Moreover, bexarotene pretreatment improved neuron survival in primary 5XFAD neurons <jats:italic>in vitro<\/jats:italic> in response to glutamate-induced excitotoxicity. The salutary effects of bexarotene were accompanied by reduced plaque burden, decreased astrogliosis, and suppression of inflammatory gene expression. Collectively, these data provide evidence that bexarotene treatment reduced neuron loss, elevated levels of markers of synaptic integrity that was linked to improved cognition and in an aggressive model of AD.<\/jats:p>","DOI":"10.1038\/srep42270","type":"journal-article","created":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T10:30:26Z","timestamp":1487241026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Neuronally-directed effects of RXR activation in a mouse model of Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"7","author":[{"given":"M. M.","family":"Mariani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Malm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Lamb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. R.","family":"Jay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Neilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Casali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Medarametla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. E.","family":"Landreth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,16]]},"reference":[{"key":"BFsrep42270_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.nbd.2014.05.019","volume":"72","author":"R Skerrett","year":"2014","unstructured":"Skerrett, R., Malm, T. & Landreth, G. Nuclear receptors in neurodegenerative diseases. Neurobiology of disease 72 Pt A, 104\u2013116, doi: 10.1016\/j.nbd.2014.05.019 (2014).","journal-title":"Neurobiology of disease"},{"key":"BFsrep42270_CR2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nri2748","volume":"10","author":"CK Glass","year":"2010","unstructured":"Glass, C. K. & Saijo, K. Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells. Nature reviews. Immunology 10, 365\u2013376, doi: 10.1038\/nri2748 (2010).","journal-title":"Nature reviews. Immunology"},{"key":"BFsrep42270_CR3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1172\/JCI27883","volume":"116","author":"N Zelcer","year":"2006","unstructured":"Zelcer, N. & Tontonoz, P. Liver X receptors as integrators of metabolic and inflammatory signaling. The Journal of clinical investigation 116, 607\u2013614, doi: 10.1172\/JCI27883 (2006).","journal-title":"The Journal of clinical investigation"},{"key":"BFsrep42270_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1146\/annurev.med.57.121304.131428","volume":"57","author":"SW Beaven","year":"2006","unstructured":"Beaven, S. W. & Tontonoz, P. Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia. Annual review of medicine 57, 313\u2013329, doi: 10.1146\/annurev.med.57.121304.131428 (2006).","journal-title":"Annual review of medicine"},{"key":"BFsrep42270_CR5","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jneuroim.2006.11.007","volume":"183","author":"CX Zhang-Gandhi","year":"2007","unstructured":"Zhang-Gandhi, C. X. & Drew, P. D. Liver X receptor and retinoid X receptor agonists inhibit inflammatory responses of microglia and astrocytes. Journal of neuroimmunology 183, 50\u201359, doi: 10.1016\/j.jneuroim.2006.11.007 (2007).","journal-title":"Journal of neuroimmunology"},{"key":"BFsrep42270_CR6","doi-asserted-by":"publisher","first-page":"6532","DOI":"10.1523\/JNEUROSCI.4586-14.2015","volume":"35","author":"JC Savage","year":"2015","unstructured":"Savage, J. C. et al. Nuclear receptors license phagocytosis by trem2+ myeloid cells in mouse models of Alzheimer\u2019s disease. The Journal of neuroscience: the official journal of the Society for Neuroscience 35, 6532\u20136543, doi: 10.1523\/JNEUROSCI.4586-14.2015 (2015).","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"BFsrep42270_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12974-014-0229-9","volume":"12","author":"T Malm","year":"2015","unstructured":"Malm, T., Mariani, M., Donovan, L. J., Neilson, L. & Landreth, G. E. Activation of the nuclear receptor PPARdelta is neuroprotective in a transgenic mouse model of Alzheimer\u2019s disease through inhibition of inflammation. Journal of neuroinflammation 12, 7, doi: 10.1186\/s12974-014-0229-9 (2015).","journal-title":"Journal of neuroinflammation"},{"key":"BFsrep42270_CR8","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1126\/science.1217697","volume":"335","author":"PE Cramer","year":"2012","unstructured":"Cramer, P. E. et al. ApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models. Science 335, 1503\u20131506, doi: 10.1126\/science.1217697 (2012).","journal-title":"Science"},{"key":"BFsrep42270_CR9","doi-asserted-by":"publisher","first-page":"7293","DOI":"10.1523\/JNEUROSCI.5198-13.2014","volume":"34","author":"A Boehm-Cagan","year":"2014","unstructured":"Boehm-Cagan, A. & Michaelson, D. M. Reversal of apoE4-driven brain pathology and behavioral deficits by bexarotene. The Journal of neuroscience: the official journal of the Society for Neuroscience 34, 7293\u20137301, doi: 10.1523\/JNEUROSCI.5198-13.2014 (2014).","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"BFsrep42270_CR10","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1016\/j.neurobiolaging.2014.03.029","volume":"35","author":"V Bomben","year":"2014","unstructured":"Bomben, V. et al. Bexarotene reduces network excitability in models of Alzheimer\u2019s disease and epilepsy. Neurobiology of aging 35, 2091\u20132095, doi: 10.1016\/j.neurobiolaging.2014.03.029 (2014).","journal-title":"Neurobiology of aging"},{"key":"BFsrep42270_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2015.12.003","volume":"277","author":"M Tachibana","year":"2015","unstructured":"Tachibana, M. et al. Rescuing effects of RXR agonist bexarotene on aging-related synapse loss depend on neuronal LRP1. Experimental neurology 277, 1\u20139, doi: 10.1016\/j.expneurol.2015.12.003 (2015).","journal-title":"Experimental neurology"},{"key":"BFsrep42270_CR12","doi-asserted-by":"publisher","first-page":"11862","DOI":"10.1523\/JNEUROSCI.1001-15.2015","volume":"35","author":"A Mounier","year":"2015","unstructured":"Mounier, A. et al. Bexarotene-Activated Retinoid X Receptors Regulate Neuronal Differentiation and Dendritic Complexity. The Journal of neuroscience: the official journal of the Society for Neuroscience 35, 11862\u201311876, doi: 10.1523\/JNEUROSCI.1001-15.2015 (2015).","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"BFsrep42270_CR13","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1523\/JNEUROSCI.3413-13.2014","volume":"34","author":"MN Nenov","year":"2014","unstructured":"Nenov, M. N. et al. Cognitive enhancing treatment with a PPARgamma agonist normalizes dentate granule cell presynaptic function in Tg2576 APP mice. The Journal of neuroscience: the official journal of the Society for Neuroscience 34, 1028\u20131036, doi: 10.1523\/JNEUROSCI.3413-13.2014 (2014).","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"BFsrep42270_CR14","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1152\/jn.00419.2014","volume":"113","author":"MN Nenov","year":"2015","unstructured":"Nenov, M. N., Tempia, F., Denner, L., Dineley, K. T. & Laezza, F. Impaired firing properties of dentate granule neurons in an Alzheimer\u2019s disease animal model are rescued by PPARgamma agonism. Journal of neurophysiology 113, 1712\u20131726, doi: 10.1152\/jn.00419.2014 (2015).","journal-title":"Journal of neurophysiology"},{"key":"BFsrep42270_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/msj.20159","volume":"77","author":"GA Elder","year":"2010","unstructured":"Elder, G. A., Gama Sosa, M. A. & De Gasperi, R. Transgenic mouse models of Alzheimer\u2019s disease. Mt Sinai J Med 77, 69\u201381, doi: 10.1002\/msj.20159 (2010).","journal-title":"Mt Sinai J Med"},{"key":"BFsrep42270_CR16","doi-asserted-by":"publisher","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley, H. et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. The Journal of neuroscience: the official journal of the Society for Neuroscience 26, 10129\u201310140, doi: 10.1523\/JNEUROSCI.1202-06.2006 (2006).","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"BFsrep42270_CR17","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3233\/JAD-2011-111778","volume":"29","author":"M Moon","year":"2012","unstructured":"Moon, M. et al. Intracellular amyloid-beta accumulation in calcium-binding protein-deficient neurons leads to amyloid-beta plaque formation in animal model of Alzheimer\u2019s disease. Journal of Alzheimer\u2019s disease: JAD 29, 615\u2013628, doi: 10.3233\/JAD-2011-111778 (2012).","journal-title":"Journal of Alzheimer\u2019s disease: JAD"},{"key":"BFsrep42270_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1750-1326-8-2","volume":"8","author":"WA Eimer","year":"2013","unstructured":"Eimer, W. A. & Vassar, R. Neuron loss in the 5XFAD mouse model of Alzheimer\u2019s disease correlates with intraneuronal Abeta42 accumulation and Caspase-3 activation. Molecular neurodegeneration 8, 2, doi: 10.1186\/1750-1326-8-2 (2013).","journal-title":"Molecular neurodegeneration"},{"key":"BFsrep42270_CR19","doi-asserted-by":"publisher","first-page":"924-c","DOI":"10.1126\/science.1235809","volume":"340","author":"NF Fitz","year":"2013","unstructured":"Fitz, N. F., Cronican, A. A., Lefterov, I. & Koldamova, R. Comment on \u201cApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models\u201d. Science 340, 924-c, doi: 10.1126\/science.1235809 (2013).","journal-title":"Science"},{"key":"BFsrep42270_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13195-016-0173-2","volume":"8","author":"JL Cummings","year":"2016","unstructured":"Cummings, J. L. et al. Double-blind, placebo-controlled, proof-of-concept trial of bexarotene Xin moderate Alzheimer\u2019s disease. Alzheimer\u2019s research & therapy 8, 4, doi: 10.1186\/s13195-016-0173-2 (2016).","journal-title":"Alzheimer\u2019s research & therapy"},{"key":"BFsrep42270_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3233\/JAD-150405","volume":"49","author":"N Pierrot","year":"2015","unstructured":"Pierrot, N. et al. Targretin Improves Cognitive and Biological Markers in a Patient with Alzheimer\u2019s Disease. Journal of Alzheimer\u2019s disease: JAD 49, 271\u2013276, doi: 10.3233\/JAD-150405 (2015).","journal-title":"Journal of Alzheimer\u2019s disease: JAD"},{"key":"BFsrep42270_CR22","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1021\/cn400100f","volume":"4","author":"K McFarland","year":"2013","unstructured":"McFarland, K. et al. Low dose bexarotene treatment rescues dopamine neurons and restores behavioral function in models of Parkinson\u2019s disease. ACS chemical neuroscience 4, 1430\u20131438, doi: 10.1021\/cn400100f (2013).","journal-title":"ACS chemical neuroscience"},{"key":"BFsrep42270_CR23","doi-asserted-by":"publisher","first-page":"250","DOI":"10.3389\/fncel.2015.00250","volume":"9","author":"J Riancho","year":"2015","unstructured":"Riancho, J., Ruiz-Soto, M., Berciano, M. T., Berciano, J. & Lafarga, M. Neuroprotective Effect of Bexarotene in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis. Frontiers in cellular neuroscience 9, 250, doi: 10.3389\/fncel.2015.00250 (2015).","journal-title":"Frontiers in cellular neuroscience"},{"key":"BFsrep42270_CR24","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1093\/brain\/awv289","volume":"138","author":"MS Natrajan","year":"2015","unstructured":"Natrajan, M. S. et al. Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelination. Brain: a journal of neurology 138, 3581\u20133597, doi: 10.1093\/brain\/awv289 (2015).","journal-title":"Brain: a journal of neurology"},{"key":"BFsrep42270_CR25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.phrs.2015.10.009","volume":"102","author":"M Certo","year":"2015","unstructured":"Certo, M. et al. Activation of RXR\/PPARgamma underlies neuroprotection by bexarotene in ischemic stroke. Pharmacological research 102, 298\u2013307, doi: 10.1016\/j.phrs.2015.10.009 (2015).","journal-title":"Pharmacological research"},{"key":"BFsrep42270_CR26","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.neurobiolaging.2008.07.022","volume":"31","author":"DZ Christensen","year":"2010","unstructured":"Christensen, D. Z., Bayer, T. A. & Wirths, O. Intracellular Ass triggers neuron loss in the cholinergic system of the APP\/PS1KI mouse model of Alzheimer\u2019s disease. Neurobiology of aging 31, 1153\u20131163, doi: 10.1016\/j.neurobiolaging.2008.07.022 (2010).","journal-title":"Neurobiology of aging"},{"key":"BFsrep42270_CR27","doi-asserted-by":"publisher","first-page":"20324","DOI":"10.1073\/pnas.0911281106","volume":"106","author":"X Hu","year":"2009","unstructured":"Hu, X. et al. Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide. Proceedings of the National Academy of Sciences of the United States of America 106, 20324\u201320329, doi: 10.1073\/pnas.0911281106 (2009).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFsrep42270_CR28","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1073\/pnas.0904532106","volume":"107","author":"RP Friedrich","year":"2010","unstructured":"Friedrich, R. P. et al. Mechanism of amyloid plaque formation suggests an intracellular basis of Abeta pathogenicity. Proceedings of the National Academy of Sciences of the United States of America 107, 1942\u20131947, doi: 10.1073\/pnas.0904532106 (2010).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFsrep42270_CR29","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3233\/JAD-140495","volume":"42","author":"L Trujillo-Estrada","year":"2014","unstructured":"Trujillo-Estrada, L. et al. Early neuronal loss and axonal\/presynaptic damage is associated with accelerated amyloid-beta accumulation in AbetaPP\/PS1 Alzheimer\u2019s disease mice subiculum. Journal of Alzheimer\u2019s disease: JAD 42, 521\u2013541, doi: 10.3233\/JAD-140495 (2014).","journal-title":"Journal of Alzheimer\u2019s disease: JAD"},{"key":"BFsrep42270_CR30","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1074\/jbc.M111.295451","volume":"287","author":"CY Lee","year":"2012","unstructured":"Lee, C. Y., Tse, W., Smith, J. D. & Landreth, G. E. Apolipoprotein E promotes beta-amyloid trafficking and degradation by modulating microglial cholesterol levels. The Journal of biological chemistry 287, 2032\u20132044, doi: 10.1074\/jbc.M111.295451 (2012).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep42270_CR31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.nbd.2008.10.006","volume":"33","author":"R Kimura","year":"2009","unstructured":"Kimura, R. & Ohno, M. Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model. Neurobiology of disease 33, 229\u2013235, doi: 10.1016\/j.nbd.2008.10.006 (2009).","journal-title":"Neurobiology of disease"},{"key":"BFsrep42270_CR32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1523\/JNEUROSCI.4622-09.2010","volume":"30","author":"DW Wesson","year":"2010","unstructured":"Wesson, D. W., Levy, E., Nixon, R. A. & Wilson, D. A. Olfactory dysfunction correlates with amyloid-beta burden in an Alzheimer\u2019s disease mouse model. The Journal of neuroscience: the official journal of the Society for Neuroscience 30, 505\u2013514, doi: 10.1523\/JNEUROSCI.4622-09.2010 (2010).","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"BFsrep42270_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1001\/archneur.55.1.84","volume":"55","author":"RI Mesholam","year":"1998","unstructured":"Mesholam, R. I., Moberg, P. J., Mahr, R. N. & Doty, R. L. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer\u2019s and Parkinson\u2019s diseases. Archives of neurology 55, 84\u201390 (1998).","journal-title":"Archives of neurology"},{"key":"BFsrep42270_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0031-9384(98)00262-5","volume":"66","author":"C Murphy","year":"1999","unstructured":"Murphy, C. Loss of olfactory function in dementing disease. Physiology & behavior 66, 177\u2013182 (1999).","journal-title":"Physiology & behavior"},{"key":"BFsrep42270_CR35","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1074\/jbc.M112.409250","volume":"288","author":"L Avrahami","year":"2013","unstructured":"Avrahami, L. et al. Inhibition of glycogen synthase kinase-3 ameliorates beta-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies. The Journal of biological chemistry 288, 1295\u20131306, doi: 10.1074\/jbc.M112.409250 (2013).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep42270_CR36","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/j.cell.2010.05.008","volume":"141","author":"JH Lee","year":"2010","unstructured":"Lee, J. H. et al. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141, 1146\u20131158, doi: 10.1016\/j.cell.2010.05.008 (2010).","journal-title":"Cell"},{"key":"BFsrep42270_CR37","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1111\/ejn.12169","volume":"37","author":"DM Wolfe","year":"2013","unstructured":"Wolfe, D. M. et al. Autophagy failure in Alzheimer\u2019s disease and the role of defective lysosomal acidification. The European journal of neuroscience 37, 1949\u20131961, doi: 10.1111\/ejn.12169 (2013).","journal-title":"The European journal of neuroscience"},{"key":"BFsrep42270_CR38","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.nbd.2011.09.001","volume":"45","author":"L Devi","year":"2012","unstructured":"Devi, L. & Ohno, M. Mitochondrial dysfunction and accumulation of the beta-secretase-cleaved C-terminal fragment of APP in Alzheimer\u2019s disease transgenic mice. Neurobiology of disease 45, 417\u2013424, doi: 10.1016\/j.nbd.2011.09.001 (2012).","journal-title":"Neurobiology of disease"},{"key":"BFsrep42270_CR39","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00401-013-1152-3","volume":"126","author":"PC Kandalepas","year":"2013","unstructured":"Kandalepas, P. C. et al. The Alzheimer\u2019s beta-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques. Acta neuropathologica 126, 329\u2013352, doi: 10.1007\/s00401-013-1152-3 (2013).","journal-title":"Acta neuropathologica"},{"key":"BFsrep42270_CR40","doi-asserted-by":"publisher","first-page":"223ra220","DOI":"10.1126\/scitranslmed.3007747","volume":"6","author":"S Caglayan","year":"2014","unstructured":"Caglayan, S. et al. Lysosomal sorting of amyloid-beta by the SORLA receptor is impaired by a familial Alzheimer\u2019s disease mutation. Science translational medicine 6, 223ra220, doi: 10.1126\/scitranslmed.3007747 (2014).","journal-title":"Science translational medicine"},{"key":"BFsrep42270_CR41","doi-asserted-by":"publisher","first-page":"767","DOI":"10.14348\/molcells.2014.0248","volume":"37","author":"J Kim","year":"2014","unstructured":"Kim, J., Yoon, H., Basak, J. & Kim, J. Apolipoprotein E in synaptic plasticity and Alzheimer\u2019s disease: potential cellular and molecular mechanisms. Molecules and cells 37, 767\u2013776, doi: 10.14348\/molcells.2014.0248 (2014).","journal-title":"Molecules and cells"},{"key":"BFsrep42270_CR42","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.neuron.2014.08.005","volume":"83","author":"C Lane-Donovan","year":"2014","unstructured":"Lane-Donovan, C., Philips, G. T. & Herz, J. More than cholesterol transporters: lipoprotein receptors in CNS function and neurodegeneration. Neuron 83, 771\u2013787, doi: 10.1016\/j.neuron.2014.08.005 (2014).","journal-title":"Neuron"},{"key":"BFsrep42270_CR43","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1194\/jlr.R300017-JLR200","volume":"45","author":"U Beffert","year":"2004","unstructured":"Beffert, U., Stolt, P. C. & Herz, J. Functions of lipoprotein receptors in neurons. Journal of lipid research 45, 403\u2013409, doi: 10.1194\/jlr.R300017-JLR200 (2004).","journal-title":"Journal of lipid research"},{"key":"BFsrep42270_CR44","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1073\/pnas.0503839103","volume":"103","author":"M Sastre","year":"2006","unstructured":"Sastre, M. et al. Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma. Proceedings of the National Academy of Sciences of the United States of America 103, 443\u2013448, doi: 10.1073\/pnas.0503839103 (2006).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFsrep42270_CR45","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3233\/JAD-2012-111661","volume":"30","author":"JL Searcy","year":"2012","unstructured":"Searcy, J. L. et al. Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer\u2019s disease. Journal of Alzheimer\u2019s disease: JAD 30, 943\u2013961, doi: 10.3233\/JAD-2012-111661 (2012).","journal-title":"Journal of Alzheimer\u2019s disease: JAD"},{"key":"BFsrep42270_CR46","doi-asserted-by":"publisher","first-page":"924-e","DOI":"10.1126\/science.1233937","volume":"340","author":"I Tesseur","year":"2013","unstructured":"Tesseur, I. et al. Comment on \u201cApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models\u201d. Science 340, 924-e, doi: 10.1126\/science.1233937 (2013).","journal-title":"Science"},{"key":"BFsrep42270_CR47","doi-asserted-by":"publisher","first-page":"9173","DOI":"10.1523\/JNEUROSCI.1000-15.2015","volume":"35","author":"BT Casali","year":"2015","unstructured":"Casali, B. T. et al. Omega-3 Fatty Acids Augment the Actions of Nuclear Receptor Agonists in a Mouse Model of Alzheimer\u2019s Disease. The Journal of neuroscience: the official journal of the Society for Neuroscience 35, 9173\u20139181, doi: 10.1523\/JNEUROSCI.1000-15.2015 (2015).","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"BFsrep42270_CR48","doi-asserted-by":"publisher","first-page":"924-f","DOI":"10.1126\/science.1235505","volume":"340","author":"K Veeraraghavalu","year":"2013","unstructured":"Veeraraghavalu, K. et al. Comment on \u201cApoE-directed therapeutics rapidly clear beta-amyloid and reverse deficits in AD mouse models\u201d. Science 340, 924-f, doi: 10.1126\/science.1235505 (2013).","journal-title":"Science"},{"key":"BFsrep42270_CR49","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ejpb.2013.12.005","volume":"87","author":"L Chen","year":"2014","unstructured":"Chen, L. et al. Bexarotene nanocrystal-Oral and parenteral formulation development, characterization and pharmacokinetic evaluation. European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 87, 160\u2013169, doi: 10.1016\/j.ejpb.2013.12.005 (2014).","journal-title":"European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V"},{"key":"BFsrep42270_CR50","doi-asserted-by":"publisher","first-page":"30538","DOI":"10.1074\/jbc.M114.600833","volume":"289","author":"LM Tai","year":"2014","unstructured":"Tai, L. M. et al. Amyloid-beta pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo . The Journal of biological chemistry 289, 30538\u201330555, doi: 10.1074\/jbc.M114.600833 (2014).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep42270_CR51","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/ajh\/hpu017","volume":"27","author":"J Zhu","year":"2014","unstructured":"Zhu, J. et al. Retinoid X receptor agonists inhibit hypertension-induced myocardial hypertrophy by modulating LKB1\/AMPK\/p70S6K signaling pathway. American journal of hypertension 27, 1112\u20131124, doi: 10.1093\/ajh\/hpu017 (2014).","journal-title":"American journal of hypertension"},{"key":"BFsrep42270_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neures.2013.10.004","volume":"79","author":"M Lyman","year":"2014","unstructured":"Lyman, M., Lloyd, D. G., Ji, X., Vizcaychipi, M. P. & Ma, D. Neuroinflammation: the role and consequences. Neuroscience research 79, 1\u201312, doi: 10.1016\/j.neures.2013.10.004 (2014).","journal-title":"Neuroscience research"},{"key":"BFsrep42270_CR53","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1523\/JNEUROSCI.22-03-00854.2002","volume":"22","author":"H Neumann","year":"2002","unstructured":"Neumann, H. et al. Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a rho-dependent mechanism. The Journal of neuroscience: the official journal of the Society for Neuroscience 22, 854\u2013862 (2002).","journal-title":"The Journal of neuroscience: the official journal of the Society for Neuroscience"},{"key":"BFsrep42270_CR54","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s10867-009-9157-9","volume":"35","author":"G Ricci","year":"2009","unstructured":"Ricci, G., Volpi, L., Pasquali, L., Petrozzi, L. & Siciliano, G. Astrocyte-neuron interactions in neurological disorders. Journal of biological physics 35, 317\u2013336, doi: 10.1007\/s10867-009-9157-9 (2009).","journal-title":"Journal of biological physics"},{"key":"BFsrep42270_CR55","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.nbd.2013.10.007","volume":"62","author":"K Bhaskar","year":"2014","unstructured":"Bhaskar, K. et al. Microglial derived tumor necrosis factor-alpha drives Alzheimer\u2019s disease-related neuronal cell cycle events. Neurobiology of disease 62, 273\u2013285, doi: 10.1016\/j.nbd.2013.10.007 (2014).","journal-title":"Neurobiology of disease"},{"key":"BFsrep42270_CR56","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11481-011-9287-2","volume":"7","author":"SL Montgomery","year":"2012","unstructured":"Montgomery, S. L. & Bowers, W. J. Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system. Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology 7, 42\u201359, doi: 10.1007\/s11481-011-9287-2 (2012).","journal-title":"Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology"},{"key":"BFsrep42270_CR57","doi-asserted-by":"publisher","first-page":"7674","DOI":"10.1074\/jbc.274.12.7674","volume":"274","author":"SY Na","year":"1999","unstructured":"Na, S. Y. et al. Retinoids inhibit interleukin-12 production in macrophages through physical associations of retinoid X receptor and NFkappaB. The Journal of biological chemistry 274, 7674\u20137680 (1999).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep42270_CR58","doi-asserted-by":"publisher","first-page":"e08009","DOI":"10.7554\/eLife.08009","volume":"4","author":"A Ito","year":"2015","unstructured":"Ito, A. et al. LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling. eLife 4, e08009, doi: 10.7554\/eLife.08009 (2015).","journal-title":"eLife"},{"key":"BFsrep42270_CR59","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cmet.2013.10.002","volume":"18","author":"X Rong","year":"2013","unstructured":"Rong, X. et al. LXRs regulate ER stress and inflammation through dynamic modulation of membrane phospholipid composition. Cell metabolism 18, 685\u2013697, doi: 10.1016\/j.cmet.2013.10.002 (2013).","journal-title":"Cell metabolism"},{"key":"BFsrep42270_CR60","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1113\/expphysiol.2005.030734","volume":"90","author":"M Pickering","year":"2005","unstructured":"Pickering, M., Cumiskey, D. & O\u2019Connor, J. J. Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Experimental physiology 90, 663\u2013670, doi: 10.1113\/expphysiol.2005.030734 (2005).","journal-title":"Experimental physiology"},{"key":"BFsrep42270_CR61","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.nlm.2009.05.001","volume":"92","author":"M Ohno","year":"2009","unstructured":"Ohno, M. Failures to reconsolidate memory in a mouse model of Alzheimer\u2019s disease. Neurobiology of learning and memory 92, 455\u2013459, doi: 10.1016\/j.nlm.2009.05.001 (2009).","journal-title":"Neurobiology of learning and memory"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep42270","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep42270.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep42270.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T20:27:10Z","timestamp":1671827230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep42270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,16]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,9,27]]}},"alternative-id":["BFsrep42270"],"URL":"https:\/\/doi.org\/10.1038\/srep42270","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,16]]},"assertion":[{"value":"15 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42270"}}